High-Dose-Rate Brachytherapy Alone for Localized Prostate Cancer in Patients at Moderate or High Risk of Biochemical Recurrence
Authors:
- Peter HoskinPHPeter Hoskin
- Ana RojasARAna Rojas
- Gerry LoweGLGerry Lowe
- Linda BryantLBLinda Bryant
- Peter OstlerPOPeter Ostler
- Rob HughesRHRob Hughes
- Jessica MilnerJMJessica Milner
- Helen CladdHCHelen Cladd
- 1 March 2012
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 82 (4) , 1376-1384
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Interstitial High-Dose-Rate Brachytherapy as Monotherapy for Early Stage Prostate Cancer: Median 8-Year Results in 301 PatientsBrachytherapy, 2010
- Correlation Between Dosimetric Parameters and Late Rectal and Urinary Toxicities in Patients Treated With High-Dose-Rate Brachytherapy Used as Monotherapy for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- High-dose-rate brachytherapy as monotherapy delivered in two fractions over one day for favorable-risk prostate cancer. Preliminary toxicity dataBrachytherapy, 2009
- Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapyBrachytherapy, 2009
- Interstitial High Dose Rate (HDR) Brachtherapy as Monotherapy for Early Stage Prostate Cancer: A Report of 206 CasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- High Dose Rate Brachytherapy (HDR-BT) as Monotherapy for Favorable Prostate Cancer: Excellent 5-Year Control Rates and Low ToxicityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancerRadiotherapy and Oncology, 2006
- The emerging role of high-dose-rate brachytherapy for prostate cancerClinical Oncology, 2005
- 3-D Conformal HDR Brachytherapy as Monotherapy for Localized Prostate CancerStrahlentherapie und Onkologie, 2004
- High Dose Rate Brachytherapy as Prostate Cancer Monotherapy Reduces Toxicity Compared to Low Dose Rate Palladium SeedsJournal of Urology, 2004